Product Information
HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.1953 per EA under NDC 13107021205. Its NADAC has been published 351 times since Dec 4, 2019.
FDA first approved this application on Sep 13, 2018. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 7.5 mg/1; mg/1
Manufacturer
Aurolife Pharma LLCNDC
13107021205
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; HYDROCODONE BITARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207709FDA Approved
9/13/2018
TE Code
AA
On Market Since
5/6/2015
Pharmacological Classes
Price Statistics
The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has been published 351 times since Dec 4, 2019, and over the history we have for it it has declined 9.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1953 per EA |
|---|---|
| All-time high | $0.6564 (Jun 10, 2020) |
| All-time low | $0.1542 (Jul 17, 2024) |
| 52-week high | $0.2254 |
| 52-week low | $0.1719 |
| Median price | $0.2478 |
| Average price | $0.2919 |
| Largest weekly change | +89.2% (Apr 22, 2020) |
| Weeks tracked | 351 |
| Tracking since | Dec 4, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.1953 per EA (NDC 13107021205), effective Aug 19, 2026.
How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has declined 9.7%. It has been tracked across 351 weekly CMS publications since Dec 4, 2019.
What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
Since Dec 4, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has ranged from a low of $0.1542 (Jul 17, 2024) to a high of $0.6564 (Jun 10, 2020), with a median of $0.2478 per EA.
Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, is $0.1741 per EA — about 11% below HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET.
Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?
HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET (NDC 13107021205) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.